676 filings
Page 4 of 34
DEFA14A
qv8db
16 Apr 21
Additional proxy soliciting materials
4:34pm
8-K
a82cjsv q2
6 Apr 21
Other Events
4:11pm
SEC STAFF
awsv9flijv
10 Mar 21
SEC staff action: Order
12:00am
CT ORDER
a6g3gdvf
4 Mar 21
Confidential treatment order
12:00am
S-8
0ai2ors3 cje
25 Feb 21
Registration of securities for employees
4:30pm
8-K
cz0mvh0fqhke
25 Feb 21
Dynavax Announces Fourth Quarter and Full Year 2020 Financial Results
4:07pm
8-K
o1skyi5qynu 2sdddotz
19 Feb 21
Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine
2:07pm
SEC STAFF
kpt2jdhjqt7fm6o1tbfo
9 Feb 21
SEC staff action: Order
12:00am
8-K
w171a
1 Feb 21
Entry into a Material Definitive Agreement
8:10am
8-K
depl2ko4uojcex
21 Jan 21
Departure of Directors or Certain Officers
9:01am
8-K
dk4fn
12 Jan 21
Departure of Directors or Certain Officers
4:24pm
8-K
v9xo gc7h
7 Jan 21
Other Events
4:10pm
8-K
wqrd28w4
5 Nov 20
Dynavax Announces Third Quarter 2020 Financial Results
4:08pm
CT ORDER
kr5o8buv8djcbu13
30 Sep 20
Confidential treatment order
10:01am
8-K
4zlsf g90h5x
24 Sep 20
Departure of Directors or Certain Officers
4:11pm
8-K
a7t jc8n8l
14 Sep 20
Other Events
9:13am
S-3ASR
3zrl6tufml4s0
6 Aug 20
Automatic shelf registration
4:44pm